These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
492 related articles for article (PubMed ID: 29286644)
1. Complexation of NAC-Derived Peptide Ligands with the C-Terminus of α-Synuclein Accelerates Its Aggregation. Jha NN; Ranganathan S; Kumar R; Mehra S; Panigrahi R; Navalkar A; Ghosh D; Kumar A; Padinhateeri R; Maji SK Biochemistry; 2018 Feb; 57(5):791-804. PubMed ID: 29286644 [TBL] [Abstract][Full Text] [Related]
2. The C-terminal α-helices of mammalian Hsc70 play a critical role in the stabilization of α-synuclein binding and inhibition of aggregation. Chaari A; Eliezer D; Ladjimi M Int J Biol Macromol; 2016 Feb; 83():433-41. PubMed ID: 26601760 [TBL] [Abstract][Full Text] [Related]
3. Binding of Noradrenaline to Native and Intermediate States during the Fibrillation of α-Synuclein Leads to the Formation of Stable and Structured Cytotoxic Species. Singh P; Bhat R ACS Chem Neurosci; 2019 Jun; 10(6):2741-2755. PubMed ID: 30917654 [TBL] [Abstract][Full Text] [Related]
4. A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders. El-Agnaf OM; Paleologou KE; Greer B; Abogrein AM; King JE; Salem SA; Fullwood NJ; Benson FE; Hewitt R; Ford KJ; Martin FL; Harriott P; Cookson MR; Allsop D FASEB J; 2004 Aug; 18(11):1315-7. PubMed ID: 15180968 [TBL] [Abstract][Full Text] [Related]
5. Comparison of α-Synuclein Fibril Inhibition by Four Different Amyloid Inhibitors. Jha NN; Kumar R; Panigrahi R; Navalkar A; Ghosh D; Sahay S; Mondal M; Kumar A; Maji SK ACS Chem Neurosci; 2017 Dec; 8(12):2722-2733. PubMed ID: 28872299 [TBL] [Abstract][Full Text] [Related]
6. Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity. Carija A; Pinheiro F; Pujols J; Brás IC; Lázaro DF; Santambrogio C; Grandori R; Outeiro TF; Navarro S; Ventura S Redox Biol; 2019 Apr; 22():101135. PubMed ID: 30769283 [TBL] [Abstract][Full Text] [Related]
7. Co-aggregation of pro-inflammatory S100A9 with α-synuclein in Parkinson's disease: ex vivo and in vitro studies. Horvath I; Iashchishyn IA; Moskalenko RA; Wang C; Wärmländer SKTS; Wallin C; Gräslund A; Kovacs GG; Morozova-Roche LA J Neuroinflammation; 2018 Jun; 15(1):172. PubMed ID: 29866153 [TBL] [Abstract][Full Text] [Related]
8. Glycosaminoglycans have variable effects on α-synuclein aggregation and differentially affect the activities of the resulting amyloid fibrils. Mehra S; Ghosh D; Kumar R; Mondal M; Gadhe LG; Das S; Anoop A; Jha NN; Jacob RS; Chatterjee D; Ray S; Singh N; Kumar A; Maji SK J Biol Chem; 2018 Aug; 293(34):12975-12991. PubMed ID: 29959225 [TBL] [Abstract][Full Text] [Related]
9. Scutellarin inhibits the uninduced and metal-induced aggregation of α-Synuclein and disaggregates preformed fibrils: implications for Parkinson's disease. Zaidi FK; Deep S Biochem J; 2020 Feb; 477(3):645-670. PubMed ID: 31939603 [TBL] [Abstract][Full Text] [Related]
10. Brazilin Inhibits α-Synuclein Fibrillogenesis, Disrupts Mature Fibrils, and Protects against Amyloid-Induced Cytotoxicity. Liu F; Wang Y; Sang J; Wei W; Zhao W; Chen B; Zhao F; Jia L; Lu F J Agric Food Chem; 2019 Oct; 67(42):11769-11777. PubMed ID: 31575115 [TBL] [Abstract][Full Text] [Related]
11. Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations. Sahay S; Ghosh D; Singh PK; Maji SK Curr Protein Pept Sci; 2017; 18(7):656-676. PubMed ID: 26972727 [TBL] [Abstract][Full Text] [Related]
12. Uncovering the Binding and Specificity of β-Wrapins for Amyloid-β and α-Synuclein. Orr AA; Wördehoff MM; Hoyer W; Tamamis P J Phys Chem B; 2016 Dec; 120(50):12781-12794. PubMed ID: 27934063 [TBL] [Abstract][Full Text] [Related]
13. An α-synuclein decoy peptide prevents cytotoxic α-synuclein aggregation caused by fatty acid binding protein 3. Fukui N; Yamamoto H; Miyabe M; Aoyama Y; Hongo K; Mizobata T; Kawahata I; Yabuki Y; Shinoda Y; Fukunaga K; Kawata Y J Biol Chem; 2021; 296():100663. PubMed ID: 33862084 [TBL] [Abstract][Full Text] [Related]
14. Structural basis of the interplay between α-synuclein and Tau in regulating pathological amyloid aggregation. Lu J; Zhang S; Ma X; Jia C; Liu Z; Huang C; Liu C; Li D J Biol Chem; 2020 May; 295(21):7470-7480. PubMed ID: 32291284 [TBL] [Abstract][Full Text] [Related]
15. Effect of curcumin analogs onα-synuclein aggregation and cytotoxicity. Jha NN; Ghosh D; Das S; Anoop A; Jacob RS; Singh PK; Ayyagari N; Namboothiri IN; Maji SK Sci Rep; 2016 Jun; 6():28511. PubMed ID: 27338805 [TBL] [Abstract][Full Text] [Related]
16. A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity. Perni M; Galvagnion C; Maltsev A; Meisl G; Müller MB; Challa PK; Kirkegaard JB; Flagmeier P; Cohen SI; Cascella R; Chen SW; Limbocker R; Sormanni P; Heller GT; Aprile FA; Cremades N; Cecchi C; Chiti F; Nollen EA; Knowles TP; Vendruscolo M; Bax A; Zasloff M; Dobson CM Proc Natl Acad Sci U S A; 2017 Feb; 114(6):E1009-E1017. PubMed ID: 28096355 [TBL] [Abstract][Full Text] [Related]
17. The conformation and the aggregation kinetics of α-synuclein depend on the proline residues in its C-terminal region. Meuvis J; Gerard M; Desender L; Baekelandt V; Engelborghs Y Biochemistry; 2010 Nov; 49(43):9345-52. PubMed ID: 20828147 [TBL] [Abstract][Full Text] [Related]
18. Structural basis for the dissociation of α-synuclein fibrils triggered by pressure perturbation of the hydrophobic core. de Oliveira GA; Marques MA; Cruzeiro-Silva C; Cordeiro Y; Schuabb C; Moraes AH; Winter R; Oschkinat H; Foguel D; Freitas MS; Silva JL Sci Rep; 2016 Nov; 6():37990. PubMed ID: 27901101 [TBL] [Abstract][Full Text] [Related]
19. Complex of EGCG with Cu(II) Suppresses Amyloid Aggregation and Cu(II)-Induced Cytotoxicity of α-Synuclein. Teng Y; Zhao J; Ding L; Ding Y; Zhou P Molecules; 2019 Aug; 24(16):. PubMed ID: 31416122 [TBL] [Abstract][Full Text] [Related]